NEW YORK ( TheStreet) -- Pharmaceutical Product Development (Nasdaq: PPDI) hit a new 52-week high Monday as it is currently trading at $33.12, above its previous 52-week high of $33.09 with 3.3 million shares traded as of four p.m. ET. Average volume has been 2.9 million shares over the past 30 days. Pharmaceutical Product Development has a market cap of $3.7 billion and is part of the health care sector and health services industry. Shares are up 21.8% year to date as of the close of trading on Friday. Pharmaceutical Product Development, Inc., a contract research organization, provides drug discovery, development, and lifecycle management services. It operates in two segments, Clinical Development Services and Laboratory Services. The company has a P/E ratio of 51.5, above the average health services industry P/E ratio of 22.5 and above the S&P 500 P/E ratio of 17.7.
- Practice your PPDI trading strategies and win cash in our stock game.